The action of the drug on the cellular response in the OVX groups was favorable, since in the period of 6 weeks there was a similarity in the average values of the percentage of immunostained cells for OC in the BGTO group when compared to the CS group, which did not have the interference of osteoporosis. The gene discussed is BGLAP; the disease is osteoporosis.